구조모아 (StructureMoa)항암 chemical structure spider web
방문Novartis Pharmaceuticals
Auto-discovered from ClinicalTrials.gov (15 linked trials). Disease-specific study endpoint: 6.35. The purpose of this study is to summarize the safety and tolerability of abatacep….
우선 정리한 핵심 프로그램입니다. 공개 출처가 있는 필드만 표시합니다.
구조화 데이터
Rheumatoid Arthritis
Rheumatoid Arthritis
Active
2026-09-10
Data Confidence · High
Development Signal · Established
CAR-T as a salvage treatment in polyrefractory RA
humanized NOD
novel therapies during periods before long-term safety data become available
구조화 데이터
novel therapies during periods before long-term safety data become available
bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model
CAR-T as a salvage treatment in polyrefractory RA
Rheumatoid Arthritis · biomarker-derived score, to capture and predict the course of active lupus nephritis (LN) in adult patients
CAR-T therapy induced profound, durable responses in extremely severe patients with seropositive PIRR
immune-mediated inflammatory arthritides
apoptosis with T cell-predominant infiltration, distinct from classic inflammatory bowel disease
biomarker-derived score, to capture and predict the course of active lupus nephritis (LN) in adult patients
bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model
구조화 데이터
mice bearing RS4;11 B-ALL xenograft
mouse
14.3
구조화 데이터
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.
구조화 데이터
ClinicalTrials.gov에 등록된 완료 예정일입니다. 추정이며 결과 발표를 단정하지 않습니다.
바이오정보모아는 연구·교육용 과학·의약품 개발 정보입니다. 진료, 진단, 치료 지침, 규제 자문이 아닙니다.
Novartis Pharmaceuticals
Auto-discovered from ClinicalTrials.gov (15 linked trials). Disease-specific study endpoint: 6.35. The purpose of this study is to summarize the safety and tolerability of abatacep….
우선 정리한 핵심 프로그램입니다. 공개 출처가 있는 필드만 표시합니다.
구조화 데이터
Rheumatoid Arthritis
Rheumatoid Arthritis
Active
2026-09-10
Data Confidence · High
Development Signal · Established
CAR-T as a salvage treatment in polyrefractory RA
humanized NOD
novel therapies during periods before long-term safety data become available
구조화 데이터
novel therapies during periods before long-term safety data become available
bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model
CAR-T as a salvage treatment in polyrefractory RA
Rheumatoid Arthritis · biomarker-derived score, to capture and predict the course of active lupus nephritis (LN) in adult patients
CAR-T therapy induced profound, durable responses in extremely severe patients with seropositive PIRR
immune-mediated inflammatory arthritides
apoptosis with T cell-predominant infiltration, distinct from classic inflammatory bowel disease
biomarker-derived score, to capture and predict the course of active lupus nephritis (LN) in adult patients
bypasses CD28 blockade to sustain T-cell cytotoxicity and improve survival in a xenograft B-ALL model
구조화 데이터
mice bearing RS4;11 B-ALL xenograft
mouse
14.3
구조화 데이터
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.
구조화 데이터
ClinicalTrials.gov에 등록된 완료 예정일입니다. 추정이며 결과 발표를 단정하지 않습니다.
바이오정보모아는 연구·교육용 과학·의약품 개발 정보입니다. 진료, 진단, 치료 지침, 규제 자문이 아닙니다.